Kuros Biosciences AG (SWX:KURN)
32.30
+0.14 (0.44%)
Oct 21, 2025, 5:31 PM CET
Kuros Biosciences AG Revenue
Kuros Biosciences AG had revenue of 63.48M CHF in the half year ending June 30, 2025, with 393.39% growth. This brings the company's revenue in the last twelve months to 103.35M, up 129.81% year-over-year. In the year 2024, Kuros Biosciences AG had annual revenue of 75.56M with 125.11% growth.
Revenue (ttm)
103.35M
Revenue Growth
+129.81%
P/S Ratio
12.12
Revenue / Employee
654.12K
Employees
122
Market Cap
1.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 75.56M | 41.99M | 125.11% |
Dec 31, 2023 | 33.56M | 15.58M | 86.61% |
Dec 31, 2022 | 17.99M | 4.17M | 30.19% |
Dec 31, 2021 | 13.82M | 9.78M | 242.04% |
Dec 31, 2020 | 4.04M | 1.48M | 57.71% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Roche Holding AG | 63.49B |
Novartis AG | 43.89B |
Sandoz Group AG | 8.42B |
Alcon | 7.97B |
Lonza Group AG | 7.09B |
Galenica AG | 4.03B |
Sonova Holding AG | 3.87B |
Galderma Group AG | 3.73B |
Kuros Biosciences AG News
- 5 days ago - Kuros 9-month Revenue Up 77%; Raises 2025 Sales Guidance - Nasdaq